Abiomed, Inc. (NASDAQ: ABMD) announced today that Michael R. Minogue, Chairman, President and Chief Executive Officer, will present at the Morgan Stanley Global Healthcare Unplugged Conference on May 3, 2007 at 9:30 a.m. ET. The conference will be held at the Ritz-Carlton in Key Biscayne, Florida.
ABOUT ABIOMED
Based in Danvers, Massachusetts, Abiomed, Inc., is a leading provider of medical devices that provide circulatory support to acute heart failure patients across the continuum of care in heart recovery. Our products are designed to enable the heart to rest, heal and recover by improving blood flow and/or performing the pumping of the heart. For additional information please visit: www.abiomed.com.
FORWARD-LOOKING STATEMENTS
This Release contains forward-looking statements, including statements regarding progress toward completion of clinical trials for Abiomed’s products, including the Impella 2.5. The Company's actual results may differ materially from those anticipated in these forward-looking statements based upon a number of factors, including uncertainties associated with hospital and patient participation in trials, potentially conflicting results of future trials, the Company’s ability to successfully obtain FDA approval of the Impella 2.5, development, testing and related regulatory approvals, complex manufacturing, high quality requirements, and other risks and challenges detailed in the Company's filings with the Securities and Exchange Commission, including its most recently filed quarterly report on Form 10-Q. Readers are cautioned not to place undue reliance on any forward-looking statements, which speak only as of the date of this Release. The Company undertakes no obligation to publicly release the results of any revisions to these forward-looking statements that may be made to reflect events or circumstances that occur after the date of this Release or to reflect the occurrence of unanticipated events.